Please ensure Javascript is enabled for purposes of website accessibility

Welcome to Regulatory Rapporteur. This site uses cookies. Read our policy.

  • Skip to main content
  • Skip to navigation
Site name
topra-logo

The Organisation for Professionals in Regulatory Affairs
Site name
Mast navigation
  • Become a member
  • Sign in
Search our site
Menu
Close menu
  • Regulatory Rapporteur - October 2026
  • Pharmaceuticals
    • Back to parent navigation item
    • Pharmaceuticals
    • Artificial intelligence
    • ATMP
    • Biologics
    • Chemistry, manufacturing and controls
    • Clinical trials
    • Non-clinical development
    • Oncology
    • Product information
    • Regulatory procedures
  • Veterinary
  • Medical devices
    • Back to parent navigation item
    • Medical devices
    • Combination products
    • In-vitro diagnostics
    • Software
    • Artificial intelligence
  • Industry news
    • Back to parent navigation item
    • Industry news
    • Industry news
      • Back to parent navigation item
      • Industry news
      • Read latest news
      • Video
  • Commentary
    • Back to parent navigation item
    • Commentary
    • Editorials
    • Podcasts
    • Thought leadership
    • Letters to the Editor
  • Collections
    • Back to parent navigation item
    • Collections
    • Interviews
    • Symposium 2025
    • Symposium 2024
    • Symposium 2023
    • Symposium 2022
    • Symposium 2021
    • Regulatory Careers Live
    • CPD supplements
      • Back to parent navigation item
      • CPD supplements
      • 2021/2022
      • 2020
      • 2019
  • JOIN TOPRA
  • topra-logo

    The Organisation for Professionals in Regulatory Affairs
  • Regulatory Rapporteur - October 2026
  • Pharmaceuticals
      • Artificial intelligence
      • ATMP
      • Biologics
      • Chemistry, manufacturing and controls
      • Clinical trials
      • Non-clinical development
      • Oncology
      • Product information
      • Regulatory procedures
    • ICH main image
      ICH Q6(R1): Harmonising specifications for chemical and biological products
    • DATA main image
      The compounding pharmaceutical data gap: The impact of structural under-representation on AI-augmented pharmacovigilance systems
    • PAEDIATRIC main image
      Moving towards one global paediatric development plan
  • Veterinary
    • VET main image
      A career in veterinary regulatory affairs: Roles and competencies across the product lifecycle
    • Jana Schalansky
      November 2025 – Contents: Veterinary medicines sessions
    • RR-June-2025-half cover _masthead
      June 2025 – Contents
    • June cover image licensed
      Veterinary medicines: Translating regulation into practice
  • Medical devices
      • Combination products
      • In-vitro diagnostics
      • Software
      • Artificial intelligence
    • VOLUME main image
      China’s volume-based procurement revolution: How policy, procurement and industrial strategy are reshaping medical device market access
    • TRACE main image
      From regulation to implementation: Medical device serialisation and traceability in India
    • 1. image 1 same image in previous MedDev updates
      Medical device standards update: July 2026
  • Industry news
      • Industry news
        • Read latest news
        • Video
    • Medical ventilator image
      UK confirms indefinite recognition of CE-marked medical devices
    • FDA pilot accelerated IND image
      FDA introduces new pilot programme to accelerate early-stage clinical research
    • EMA pre-submission pilot 2
      EMA launches new pre-submission interactions model pilot
  • Commentary
      • Editorials
      • Podcasts
      • Thought leadership
      • Letters to the Editor
    • Final cover image
      Clinical trial design and real-world evidence: What happens to the evidence next?
    • RegRapPod Website Graphic 800x533px (6.4 ratio)
      RegRapPod − InConversation with TMC Pharma
    • cover image
      Asia-Pacific: A changing regulatory landscape
  • Collections
      • Interviews
      • Symposium 2025
      • Symposium 2024
      • Symposium 2023
      • Symposium 2022
      • Symposium 2021
      • Regulatory Careers Live
      • CPD supplements
        • 2021/2022
        • 2020
        • 2019
    • TOPRA_assets-banner
      Closing the gap between quality and regulatory delays with Scilife’s eQMSSponsored by Scilife | Electronic quality management software for life sciences
    • Banner_new
      Streamline medical device compliance with BSI Compliance NavigatorSponsored by The UK's National Standards Body
    • AdobeStock_59790119
      The Olaratumab experience
  • JOIN TOPRA
  • More from navigation items
Pharmaceuticals

November 2024 – Contents

  • No comments

 

RR-Nov-2024-Half-Cover

Regulatory
Rapporteur

 

Write to the Editor at publications@topra.org

November 2024  |  Vol. 21  |  No. 10

 

EDITORIAL

Improving health outcomes through regulatory excellence

Cover option 1 MichaelKipping

READ HERE

By Kornelia Grein, Sobhey Nassar and Marie Uguen

 

HUMAN MEDICINES

Human medicines sessions

SabineHaubenreisser

READ THE SESSION SUMMARIES HERE

 

MEDICAL DEVICES/IVDS

Medical devices/IVDs sessions   

MD1 -MargarethJorvid

READ THE SESSION SUMMARIES HERE

 

VETERINARY MEDICINES

Veterinary medicines sessions

VM1 - RickClayton

READ THE SESSION SUMMARIES HERE

 

PARALLEL SESSION

PS1: Resolving specific development hurdles via scientific advice

PS1 - SandraLourenço

READ HERE

By Ophélie Poujade

 

PARALLEL SESSION

PS2: Patient experience data – The next steps towards medicines evaluation

PS2 - JuanGarciaBurgos

READ HERE

By Anna Koptina

 

SME, ACADEMIA AND START-UPS

SME: Regulatory updates for SME, academia and start-ups

SME -MarjonPasmooij

READ HERE

By Marie Uguen

 

ANNUAL LECTURE

The TOPRA annual lecture: Status of global health  

AnnualLecture - IlonaKickbusch

READ HERE

By Margareth Jorvid

 

Topics

  • 2024
  • Human medicines
  • IVD
  • Medical Devices
  • November 2024
  • Pharmaceuticals
  • Symposium 2024
  • Veterinary
  • No comments

More from Pharmaceuticals

  • Half cover
    Contents

    Regulatory Rapporteur September 2026 – Contents

  • EXCIPIENT main image
    Journal

    Regulatory reforms in China: Strengthening excipient quality and accession to PIC/S

    2026-09-03T15:21:00Z

    By Janine Jamieson

  • TGA main image
    Journal

    Pathways to medicine registration in Australia

    2026-09-01T15:05:00Z

    By Cecile Cabadie-Taib

  • Half cover_final
    Contents

    Regulatory Rapporteur July/August 2026 – Contents

  • AdobeStock_2031070488_main image
    Journal

    Drug development and regulatory pathways across therapeutic areas

    2026-07-01T14:45:00Z

    By Dr Asha Kattige, Dan Cafaro, Dr Bethany Aykroyd and Basia Grodynska

  • AdobeStock_230080191_main image
    Journal

    Navigating the regulatory landscape of adverse events following immunisation: Current challenges and future perspectives

    2026-06-30T15:16:00Z

    By Dakshatha M, Shivanand K Mutta, Venugopal N and Sateesha SB

Related articles

  • Medical ventilator image
    Industry news

    UK confirms indefinite recognition of CE-marked medical devices

    2026-10-23T13:32:00Z

    By Claire McDermott

  • ICH main image
    Journal

    ICH Q6(R1): Harmonising specifications for chemical and biological products

    2026-10-07T10:14:00Z

    By Francisco Baptista and Marta Silva

  • DATA main image
    Journal

    The compounding pharmaceutical data gap: The impact of structural under-representation on AI-augmented pharmacovigilance systems

    2026-10-07T08:48:00Z

    By Trina Das

  • PAEDIATRIC main image
    Journal

    Moving towards one global paediatric development plan

    2026-10-06T15:07:00Z

    By Beatrix Friedeberg, Mette Due Theilade Thomsen, Annabel Bonsu and Evgenia Mengou

  • COMBINE main image
    Journal

    COMBINE EU pilots: Roche’s experience as first pilot participants

    2026-10-06T14:11:00Z

    By Valentina Geisseler-Homann and Deepa Subramaniyan

  • FINLAND main image
    Journal

    Multistakeholder collaboration to translate the ICH GCP E6(R3) guideline into Finnish: Supporting clinical trial conduct in Finland

    2026-10-06T13:25:00Z

    By Satu Johanna Siiskonen, Sanna Laine, Nina Airla, Niina Laaksonen, Pirkko Lepola, Märt Vesinurm and Anne Timonen

No comments yet

You're not signed in.

Only registered users can comment on this article.

Sign in Register
  • What is Regulatory Affairs?
  • TOPRA Membership
  • Regulatory Rapporteur Editorial Board
  • Regulatory Rapporteur Editorial Area
  • Future Focus Topics
  • FAQs
  • Glossary
  • Privacy Policy
  • ISSN 2755-5070 (online)

    ISSN 1742-8955 (print - legacy)

Regulatory Rapporteur

The peer-reviewed journal, published 11 times per year and available free to TOPRA members.

Follow TOPRA
topra-logo

The Organisation for Professionals in Regulatory Affairs

TOPRA office
TOPRA Publishing, Third floor, City Reach, 5 Greenwich View Place, London E14 9NN, UK
Tel: +44 (0) 20 7510 2560
Email: publications@topra.org

TOPRA AISBL
Blvd du Souverain 280, 1160 Brussels, Belgium
Tel: +32 (0) 2 808 72 70

  • Contact us
  • Copyright © 2015-2026 The Organisation for Professionals in Regulatory Affairs Ltd. t/a Regulatory Rapporteur - All rights reserved

Site powered by Webvision Cloud